Research Project

RP-2556-LG

The effect of allografting on outcomes of older and fit patients with AML treated with decitabine and intensive chemotherapy

Back to result

Project Status

Ongoing

Dates

Project start date: 19-Sep-2025

Type Data

Clinical Data

Type Research

Prognostic/predictive/subgroups

Participating groups

  • EORTC Leukemia Group

Project Leads

  • Dr. Gerwin Huls (University Medical Center Groningen - Netherlands)
  • Dr. Michael Luebbert (Universitaetsklinikum Freiburg - Germany)

Linked Studies

EORTC-1301-LG

10-day decitabine versus conventional chemotherapy (“3+7”) followed by allografting in AML patients >= 60 years: a randomized phase III study of the EORTC Leukemia Group, CELG, GIMEMA and German MDS Study Group